BIO at 25 – How it all began

The Biotechnology Innovation Organization (BIO) got its start through a need to come together to create one voice for a fledgling industry.  So much has happened in 25 years.  Watch the video to learn more

As BIO celebrates its 25-year anniversary, the upcoming BIO International Convention June 4-7 at the Boston Convention and Exhibition Center will highlight the organization’s past and imagine the future

AZBio Member News

 Dr. Megha Padi Arrives from String Theory Background at Harvard to Expand Collaboration in Bioinformatics at UA Cancer Center

Megha Padi, PhD, harnesses the computational power of bioinformatics to learn more about cancer and how best to treat it — and empowers other cancer researchers to do the same.

INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

INSYS Therapeutics, Inc. (NASDAQ:INSY) announced plans to advance clinical research of dronabinol inhalation using a novel and patented breath-actuated device—licensed from U.K.-based Senzer Ltd. and accepted by the U.S. Food and Drug Administration (FDA) under an investigational new drug (IND) filing—in the second half of 2018.

HonorHealth and TransMed Systems Collaborate To Accelerate Patient Access To Clinical Trials

Collaboration will accelerate patient access to clinical trials through advanced predictive modeling tools and patient screening technologies

HTG Promotes John Lubniewski to President and Chief Operating Officer

Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer

RightBio Metrics Receives Innovative Technology Contract from Vizient, Inc. for RightSpotpH® Indicators

Posted on Mon/16/April by AZBio

RightBio Metrics announced its RightSpotpH® indicator has received an innovative technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country.

VisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)

 VisionGate Reports Important New Research at the 2018 AACR Annual Meeting on how its Cell-CT™ platform can detect subtle changes in cellular and nuclear morphology of cancer-associated cells (CACs) as a result of the cancer field effect. 

Opportunity Alerts

Looking for Investors?  Applications are open for White Hat 2018

MDMA Annual Meeting – May 2nd – Washington DC

Plan to attend MDMA’s 2018 Annual Meeting in our Nation’s Capital, May 2-4, 2018. MDMA’s Annual Meeting will cover key issues impacting the United States’ leadership position in med tech innovation, and how we can all help shape the regulatory and legislative agendas. This year’s meeting will provide the latest on regulatory, reimbursement, compliance and international trends, as well interactive sessions with top policy makers from FDA, CMS and more. 

RESI Boston – June 4, 2018 – Marriott Copley Square

 Tell us who inspires you…

Nominations are open for the 2018 AZBio Awards.  Learn More 
Applications are now open for the Student Discovery Zone.  Learn More

Post your open career opportunities today at  Jobs.AZBio.org

Do YOU have news to share with our community? 

Send your news and events to JKW@AZBio.org. 

(For better formatting, please do not send PDF’s.)

Get Connected – Sign up today!